by Chris Wood
Casey Research
Editor’s note: Today, we’re featuring an eye-opening essay form Chris Wood, Casey’s lead tech analyst.
Chris has a long track record of spotting huge tech trends before the masses, and that’s led to some incredible gains for his readers.
For example, when Chris recognized the potential of robotic surgery early on, he recommended buying MAKO Surgical. Just seven months later, his subscribers cashed out for a 147% gain. In 2012, his subscribers made 167% in just eight months when Chris recommended Celsion, a cancer research company unknown at the time. In 2013, subscribers had a chance to book 197% gains in just seven months on a revolutionary biopharmaceutical company.